51 – 58 of 58
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis.
(
- Contribution to journal › Article
- 2009
-
Mark
Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations
(
- Contribution to journal › Article
- 2008
-
Mark
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
(
- Contribution to journal › Article
- 2007
-
Mark
Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study
(
- Contribution to journal › Article
-
Mark
Gender, body weight, disease activity, and previous radiotherapy influence the response to pegvisomant
(
- Contribution to journal › Article
- 2006
-
Mark
The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: A meta-analysis of the current literature
(
- Contribution to journal › Article
- 2005
-
Mark
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
(
- Contribution to journal › Article
- 1995
-
Mark
Quality of life in adults with growth hormone (GH) deficiency : response to treatment with recombinant human GH in a placebo-controlled 21-month trial
(
- Contribution to journal › Article